HYPOTHALAMIC PSEUDOPUBERTY
\hˌa͡ɪpə͡ʊθalˈamɪk sˈuːdə͡ʊpjˌuːbəti], \hˌaɪpəʊθalˈamɪk sˈuːdəʊpjˌuːbəti], \h_ˌaɪ_p_əʊ_θ_a_l_ˈa_m_ɪ_k s_ˈuː_d_əʊ_p_j_ˌuː_b_ə_t_i]\
Sort: Oldest first
-
Neoplastic, inflammatory, infectious, and other diseases of the hypothalamus. Clinical manifestations include appetite disorders; AUTONOMIC NERVOUS SYSTEM DISEASES; SLEEP DISORDERS; behavioral symptoms related to dysfunction of the LIMBIC SYSTEM; and neuroendocrine disorders.
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.
Nearby Words
- hypothalamic overactivity syndromes
- hypothalamic paraventricular nucleus
- hypothalamic pituitary neoplasm
- hypothalamic pituitary neoplasms
- hypothalamic pseudopuberties
- Hypothalamic Pseudopuberty
- hypothalamic release inhibiting hormone receptors
- hypothalamic releasing factor
- hypothalamic releasing hormone
- hypothalamic releasing hormone receptors
- hypothalamic substance p